June 19, 2017

Medlab Clinical (ASX:MDC) has received approvals to begin human trials of two different cannabis based medicines – NanaBis and NanaBidial. NanaBis is packaged as a mouth spray and will be clinically tested in advanced stage cancer patients with intractable pain. The drug is expected to meet a global need for better pain management, with research […]